1
|
Monnin C, Besutti M, Ecarnot F, Guillon B, Chatot M, Chopard R, Yahia M, Meneveau N, Schiele F. Cognitive dysfunction among patients referred for transcatheter aortic valve implantation: results of the Montreal Cognitive Assessment and clinical impact at 6 months. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.2816] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Detection of Cognitive Dysfunction (CD) is not routinely performed among patients undergoing Transcatheter Aortic Valve Implantation (TAVI). We sought to determine whether CD has an impact on the clinical course of these patients, during hospitalization at the time of TAVI and up to 6 months afterwards.
Methods
The MoCA was performed before TAVI by an experienced operator in an unselected population of patients referred for TAVI. CD was defined according to the MoCA score: No CD if score ≥26, mild CD if score 18–25, moderate if 10–17 and severe if <10. Multivariate Cox logistic regression analysis was used to determine the impact of CD on procedural success of TAVI, length of stay, 6 month survival, re-admission, and change in clinical status (changes in NYHA class and/or functional status).
Results
MoCA was performed in 83 consecutive patients. TAVI was performed using femoral access and local anesthesia in all patients. There were no procedural deaths, and 2 deaths at 6 months. The median age was 85 years, and median Euroscore I was 11.62. The median MOCA score was 22, CD was excluded in 17 (20%), mild in 50 (60%), moderate in 15 (18%) and severe in one patient. No difference was observed in rate of procedural success, 6 month mortality, re-admission, degree of dyspnea by NYHA between the different cognitive groups. Length of stay after the TAVI procedure was lower in patients without CD, compared to those with CD at any level: 3±1 days versus 4.3±1 days, p=0.045, and p=0.02 by multivariate analysis (figure).
Conclusion
Among patients referred for TAVI, mild or moderate CD was observed in 80% of patients. Patients without CD had a shorter length of stay at the time of TAVI, but CD was not associated with worse prognosis or clinical status at 6 months.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- C Monnin
- University Hospital of Besancon, Besancon, France
| | - M Besutti
- University Hospital of Besancon, Besancon, France
| | - F Ecarnot
- University Hospital of Besancon, Besancon, France
| | - B Guillon
- University Hospital of Besancon, Besancon, France
| | - M Chatot
- University Hospital of Besancon, Besancon, France
| | - R Chopard
- University Hospital of Besancon, Besancon, France
| | - M Yahia
- University Hospital of Besancon, Besancon, France
| | - N Meneveau
- University Hospital of Besancon, Besancon, France
| | - F Schiele
- University Hospital of Besancon, Besancon, France
| |
Collapse
|
2
|
Chopard R, Piazza G, Falvo N, Ecarnot F, Besutti M, Capellier G, Schiele F, Badoz M, Meneveau N. An original risk score to predict early major bleeding in acute pulmonary embolism: the Syncope, Anemia, Renal Dysfunction (PE-SARD) bleeding score. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.1926] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Improved prediction of the risk of early major bleeding in pulmonary embolism (PE) is needed to optimize acute management.
Methods
Using data from a multicenter prospective registry including 2,754 patients, we performed multivariable logistic regression analysis to build a risk score to predict early (up to hospital discharge) major bleeding events. We validated the endpoint model internally using bootstrapping in the derivation dataset by sampling with replacement for 500 iterations. We compared the performance of this novel score to that of the VTE-BLEED and RIETE models.
Results
Multivariate regression identified three predictors for the occurrence of 82 major bleeds (3.0%): Syncope (+1.5 points), Anemia defined by a hemoglobin level <12 g/dL (+2.5 points), and Renal Dysfunction defined by a glomerular filtration rate <60 mL/min (+1 point). The PE-SARD bleeding score was calculated by summing all the components. Overall, 52.2% of patients were classified as low bleeding-risk (score, 0 point), 35.2% intermediate-risk (score, 1–2.5 points), and 12.6% high-risk (score >2.5 points). Cumulative observed bleeding rates increased with increasing risk group, from 0.9% in the low-risk group to 9.0% in the high-risk group. The C-index was 0.744 (95% CI, 0.73–0.76) and Brier score 0.028 in the derivation cohort. Similar values were calculated from internal bootstrapping. Performance of the PE-SARD score was better than that observed with the VTE-BLEED and RIETE scores (figure).
Conclusions
The PE-SARD bleeding risk score is an original, user-friendly score to estimate the risk of early major bleeding in patients with acute PE.
Funding Acknowledgement
Type of funding sources: None. Figure 1
Collapse
Affiliation(s)
- R Chopard
- University Hospital of Besancon, Besancon, France
| | - G Piazza
- Brigham and Women'S Hospital, Harvard Medical School, Boston, United States of America
| | - N Falvo
- University Hospital of Dijon, Dijon, France
| | - F Ecarnot
- University Hospital of Besancon, Besancon, France
| | - M Besutti
- University Hospital of Besancon, Besancon, France
| | - G Capellier
- University Hospital of Besancon, Besancon, France
| | - F Schiele
- University Hospital of Besancon, Besancon, France
| | - M Badoz
- University Hospital of Besancon, Besancon, France
| | - N Meneveau
- University Hospital of Besancon, Besancon, France
| |
Collapse
|
3
|
Mathonier C, Badoz M, Besutti M, Schiele F, Meneveau N, Guillon B, Chopard R. Available bleeding scoring systems poorly predict major bleeding in the acute phase of pulmonary embolism. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.1925] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Background
Bleeding prediction scores may help to guide acute management of patients with pulmonary embolism (PE). However, existing scoring systems have not been validated for in-hospital assessment. We aimed to compare 6 available bleeding scores, in a real-life cohort for the prediction of major in-hospital bleeding.
Methods
We recorded in-hospital characteristics of 2,754 PE patients included in a prospective observational multicenter cohort study contributing 18,028 person-days of follow-up. We assessed the VTE-BLEED, RIETE, ORBIT, HEMORRA2HAGES, ATRIA, and HAS-BLED scores at baseline. ISTH-defined bleeding events were independently adjudicated. The accuracy of the scores for the prediction of in-hospital bleeding was evaluated and compared.
Results
We observed 82 first in-hospital major bleeding events (3.0% (95% CI, 2.4–3.7)). Overall, the predictive power of bleeding scores was poor, with a C index ranging from 0.57 to 0.69 (Figure 1). The RIETE score had the numerically highest model fit and best discriminatory capacity, but without reaching statistical significance versus the ORBIT, HEMORR2HAGES, and ATRIA scores. The VTE-BLEED and HAS-BLED scores had significantly lower C indices, integrated discrimination improvement, and net reclassification improvement compared to the four others.
Conclusion
Currently available scoring systems have insufficient accuracy for the prediction of in-hospital major bleeding in patients with acute PE. The development of acute-PE-specific risk scores is needed to optimally target patients that warrant bleeding-prevention strategies.
Funding Acknowledgement
Type of funding sources: None. Figure 1
Collapse
Affiliation(s)
- C Mathonier
- University Hospital of Besancon, Besancon, France
| | - M Badoz
- University Hospital of Besancon, Besancon, France
| | - M Besutti
- University Hospital of Besancon, Besancon, France
| | - F Schiele
- University Hospital of Besancon, Besancon, France
| | - N Meneveau
- University Hospital of Besancon, Besancon, France
| | - B Guillon
- University Hospital of Besancon, Besancon, France
| | - R Chopard
- University Hospital of Besancon, Besancon, France
| |
Collapse
|
4
|
Monnin C, Besutti M, Ecarnot F, Guillon B, Chatot M, Chopard R, Yahia M, Meneveau N, Schiele F. Assessment of cognitive dysfunction using the Montreal Cognitive Assessment test: rate, severity and comparison with the Clock test alone in a population of patients referred for TAVI. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.3080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Although not recommended in routine practice, the detection and quantification of Cognitive Dysfunction (CD) in older patients might have an impact on clinical decisions. We assessed the rate and severity of CD in an unselected population of patients referred for Transcatheter Aortic Valve Implantation (TAVI) using the Montreal Cognitive Assessment (MoCA) and using the Clock Drawing Test (ClockT) alone.
Methods
The MoCA was performed before TAVI by an experienced operator. The ClockT was scored out of 10 points according to the Rouleau rating scale. CD was defined according to the MoCA score: No CD if score ≥26, mild CD if score 18–25, moderate if 10–17 and severe if <10. Inter-observer reliability of scoring on the ClockT was estimated with the Bland-Altman method. Agreement between MoCA scores and the ClockT for ruling out and for detecting CD were measured with the Kappa coefficient.
Results
MoCA was performed in 83 consecutive patients referred for TAVI, median age 85 years. The mean time required for assessment was 11±2 min for the MoCA and 3±2 min for the ClockT. The mean MoCA score was 21±4.5: CD was excluded in 17 (20%) pts, mild CD was found in 50 (60%), moderate in 15 (18%) and severe in one (1%). The median ClockT score was 8 (interquartile 6; 9), with excellent inter-observer concordance (Kappa= 0.84). Overall, 51% of the variance of the MoCA score was explained by the ClockT alone according to multiple regression. A ClockT <7 detected a group with significantly lower MoCA score, compared to pts with higher ClockT scores (figure).
Conclusion
Among patients referred for TAVI, CD can be excluded using the MoCA test in 20%, while moderate or severe CD is observed in 18%. The ClockT alone is faster to implement, reliable to interpret and enabled detection of patients with moderate CD when Rouleau scoring was <7.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- C Monnin
- University Hospital of Besancon, Besancon, France
| | - M Besutti
- University Hospital of Besancon, Besancon, France
| | - F Ecarnot
- University Hospital of Besancon, Besancon, France
| | - B Guillon
- University Hospital of Besancon, Besancon, France
| | - M Chatot
- University Hospital of Besancon, Besancon, France
| | - R Chopard
- University Hospital of Besancon, Besancon, France
| | - M Yahia
- University Hospital of Besancon, Besancon, France
| | - N Meneveau
- University Hospital of Besancon, Besancon, France
| | - F Schiele
- University Hospital of Besancon, Besancon, France
| |
Collapse
|
5
|
Chopard R, Nielsen P, Ius F, Pilichowski H, Meneveau N. Use of mechanical pulmonary reperfusion and fibrinolysis in acute massive pulmonary embolism requiring extracorporeal membrane oxygenation support: a systematic review and meta-analysis. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.1924] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background and objectives
The optimal pulmonary revascularization strategy in acute massive pulmonary embolism (PE) requiring the implantation extra corporeal membrane oxygenation remains controversial, and data are sparse.
Methods
We conducted a systematic review and meta-analysis of available evidence regarding the use of mechanical reperfusion (i.e. surgical or catheter-based embolectomy) and fibrinolytic strategies (i.e. systemic fibrinolysis, catheter-directed fibrinolysis, or as stand-alone therapy) in terms of mortality and bleeding outcomes.
Results
The literature search identified 835 studies, 17 of which were included or a total of 321 PE patients with ECMO. In total, 31.1% were treated with mechanical pulmonary reperfusion, while 78.9% received fibrinolytic strategies. The mortality rate was 23.0% in the mechanical reperfusion group and 43.1% in the fibrinolysis group (Figure). The pooled OR for mortality with mechanical reperfusion was 0.46 (95% CI, 0.213–0.997; I2=28.3%) versus fibrinolysis. The rate of bleeding in PE patients under ECMO was 29.1% in the mechanical reperfusion group and 26.0% in the fibrinolytic reperfusion (OR, 1.09; 95% CI, 0.46–2.54; I2=0.0%) among 10 eligible studies with available bleeding data. The meta-regression model did not identify any relationship between the covariates “more than one pulmonary reperfusion therapy” and “ECMO implantation before pulmonary reperfusion therapy”, and outcomes.
Conclusions
The results of the present meta-analysis and meta-regression suggest that surgical embolectomy yields the best results, regardless of the timing of VA-ECMO implantation in the reperfusion timeline, and regardless of whether fibrinolysis has been administered or not.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- R Chopard
- University Hospital of Besancon, Besancon, France
| | - P Nielsen
- Aalborg University Hospital, Aalborg, Denmark
| | - F Ius
- Hannover Medical School, Hannover, Germany
| | | | - N Meneveau
- University Hospital of Besancon, Besancon, France
| |
Collapse
|
6
|
Sanchez O, Benhamou Y, Bertoletti L, Constans J, Couturaud F, Delluc A, Elias A, Fischer AM, Frappé P, Gendron N, Girard P, Godier A, Gut-Gobert C, Laporte S, Mahé I, Mauge L, Meneveau N, Meyer G, Mismetti P, Parent F, Pernod G, Quéré I, Revel MP, Roy PM, Salaün PY, Smadja DM, Sevestre MA. [Recommendations for best practice in the management of venous thromboembolic disease in adults. Long version]. Rev Mal Respir 2021; 38 Suppl 1:e1-e6. [PMID: 31280989 DOI: 10.1016/j.rmr.2019.05.038] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- O Sanchez
- Université de Paris, Service de pneumologie et soins intensifs, AH-HP, hôpital Européen Georges-Pompidou, 75015 Paris, France; F-CRIN INNOVTE, 42055 Saint-Étienne cedex 2, France.
| | - Y Benhamou
- Service de médecine interne, Normandie université UNI Rouen U1096, CHU Charles-Nicolle, 76000 Rouen, France
| | - L Bertoletti
- F-CRIN INNOVTE, 42055 Saint-Étienne cedex 2, France; Inserm UMR1059, Inserm, CIC-1408, équipe dysfonction vasculaire et hémostase, service de médecine vasculaire et thérapeutique, CHU de Saint-Étienne, université Jean-Monnet, 42000 Saint-Étienne, France
| | - J Constans
- Service de médecine vasculaire, hôpital Saint-André, université de Bordeaux, 33000 Bordeaux, France
| | - F Couturaud
- F-CRIN INNOVTE, 42055 Saint-Étienne cedex 2, France; Département de médecine interne et pneumologie, EA3878-GETBO, CIC Inserm1412, université de Bretagne occidentale, centre hospitalo-universitaire de Brest, 29200 Brest, France
| | - A Delluc
- F-CRIN INNOVTE, 42055 Saint-Étienne cedex 2, France; EA 3878 GETBO, université de Bretagne occidentale, 29200 Brest, France
| | - A Elias
- F-CRIN INNOVTE, 42055 Saint-Étienne cedex 2, France; Département de médecine vasculaire, hôpital Sainte-Musse, 83100 Toulon, France
| | - A-M Fischer
- F-CRIN INNOVTE, 42055 Saint-Étienne cedex 2, France; Service d'hématologie biologique hôpital européen Georges-Pompidou, université Paris Descartes, Sorbonne Paris Cité, Assistance publique-Hôpitaux de Paris, 75015 Paris, France
| | - P Frappé
- Inserm UMR 1059 Sainbiose DVH, Inserm CIC-EC 1408, département de médecine générale, université de Saint-Étienne, 42000 Saint-Étienne, France
| | - N Gendron
- Inserm UMR 1148, laboratoire d'hématologie, hôpital Bichat-Claude-Bernard, université Paris Diderot, Sorbonne Paris Cité, AP-HP, 75018 Paris, France
| | - P Girard
- Institut du Thorax-Curie-Montsouris, l'institut Mutualiste Montsouris, 75014 Paris, France
| | - A Godier
- Inserm UMR-S 1140, service d'anesthésie réanimation, hôpital européen Georges-Pompidou, AP-HP, 75015 Paris, France
| | - C Gut-Gobert
- F-CRIN INNOVTE, 42055 Saint-Étienne cedex 2, France; Département de médecine interne et pneumologie, EA3878-GETBO, CIC Inserm1412, université de Bretagne occidentale, centre hospitalo-universitaire de Brest, 29200 Brest, France
| | - S Laporte
- F-CRIN INNOVTE, 42055 Saint-Étienne cedex 2, France; Inserm, unité de recherche clinique, SAINBOIS U1059 équipe DVH, hôpital Nord, université Jean-Monnet, université de Lyon, innovation, pharmacologie, CHU Saint-Étienne, 42000 Saint-Étienne, France
| | - I Mahé
- F-CRIN INNOVTE, 42055 Saint-Étienne cedex 2, France; Service de médecine interne, hôpital Louis-Mourier, université Paris 7, Assistance publique-Hôpitaux de Paris, 92700 Colombes, France; Inserm UMR S1140, 75006 Paris, France
| | - L Mauge
- UMR-S 970, Paris-Cardiovascular Research Center (PARCC), service d'hématologie biologique, hôpital européen Georges-Pompidou, université Paris Descartes, Sorbonne Paris Cité, Assistance publique-Hôpitaux de Paris, 75015 Paris, France
| | - N Meneveau
- F-CRIN INNOVTE, 42055 Saint-Étienne cedex 2, France; Service de cardiologie, EA3920, université de Bourgogne-Franche Comté, CHU Jean-Minjoz, boulevard Fleming, 25030 Besançon cedex, France
| | - G Meyer
- F-CRIN INNOVTE, 42055 Saint-Étienne cedex 2, France; Université de Paris, Service de pneumologie et soins intensifs, AH-HP, Hôpital Européen Georges Pompidou, 75015 Paris, France; Inserm UMRS 970, 75015 Paris, France; Inserm CIC 1418, 75015 Paris, France
| | - P Mismetti
- F-CRIN INNOVTE, 42055 Saint-Étienne cedex 2, France; Inserm, SAINBOIS U1059 équipe DVH, unité de recherche clinique, innovation, pharmacologie, service de médecine vasculaire et thérapeutique, hôpital Nord, université Jean-Monnet, université de Lyon, CHU Saint-Étienne, 42000 Saint-Étienne, France
| | - F Parent
- Service de pneumologie, centre de référence de l'hypertension pulmonaire, hôpital Bicêtre, faculté de médecine, université Paris-Sud, université Paris-Saclay, AP-HP, 94270 Le Kremlin-Bicêtre, France; Inserm UMR-S 999, hôpital Marie-Lannelongue, 92350 Le Plessis-Robinson, France
| | - G Pernod
- F-CRIN INNOVTE, 42055 Saint-Étienne cedex 2, France; Service universitaire de médecine vasculaire, CNRS, TIMC-IMAG UMR-5525, Thèmas, CHU Grenoble, université Grenoble Alpes, 38700 La Tronche, France
| | - I Quéré
- F-CRIN INNOVTE, 42055 Saint-Étienne cedex 2, France; Département de médecine vasculaire, centre de référence des maladies vasculaires rares, EA2992, université de Montpellier, hôpital Saint-Éloi, CHU de Montpellier, 34295 Montpellier cedex 5, France
| | - M-P Revel
- Service de radiologie A, hôpital Cochin, université Paris Descartes, Sorbonne Paris Cité, Assistance publique-Hôpitaux de Paris, 75014 Paris, France
| | - P-M Roy
- F-CRIN INNOVTE, 42055 Saint-Étienne cedex 2, France; Département de médecine d'urgence et service de médecine vasculaire, CHU d'Angers, 49000 Angers, France; Institut Mitovasc, UMR 1083, UFR santé, université d'Angers, 49000 Angers, France
| | - P-Y Salaün
- Inserm EA3878 (GETBO), service de médecine nucléaire, université de Bretagne occidentale, CHRU de Brest, 29200 Brest, France
| | - D M Smadja
- F-CRIN INNOVTE, 42055 Saint-Étienne cedex 2, France; Unversité de Paris, Service d'hématologie, AH-HP, Hôpital Européen Georges-Pompidou, 75015 Paris, France; Laboratoire de recherche biochirurgicale, fondation Carpentier, Innovations Thérapeutiques en Hémostase, INSERM UMRS 1140, 75006 Paris, France
| | - M-A Sevestre
- F-CRIN INNOVTE, 42055 Saint-Étienne cedex 2, France; Service de médecine vasculaire, EA 7516 Chimère, CHU d'Amiens, 80080 Amiens, France
| |
Collapse
|
7
|
Mathonier C, Chopard R, Ecarnot F, Falvo N, Kalbacher E, Capellier G, Schiele F, Meneveau N. Accuracy of available scoring systems for prediction of in-hospital major bleeding in acute pulmonary embolism patients. Archives of Cardiovascular Diseases Supplements 2021. [DOI: 10.1016/j.acvdsp.2020.10.176] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
8
|
Chopard R, Mathonier C, Ecarnot F, Falvo N, Kalbacher E, Capellier G, Schiele F, Meneveau N. An original risk scheme to predict in-hospital major bleeding in acute pulmonary embolism: The Syncope, Troponin, Anemia, Anti-platelet therapy, Renal dysfunction (STAR) bleeding score. Archives of Cardiovascular Diseases Supplements 2021. [DOI: 10.1016/j.acvdsp.2020.10.175] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
9
|
Didier R, Le Ven F, Eltchaninoff H, Nasr B, Lefevre T, Fajadet J, Teiger E, Carrie D, Meneveau N, Ghostine S, Souteyrand G, Cuisset T, Le Breton H, Inug B, Gilard M. High post-procedural transvalvular gradient or delayed gradient increase after transcatheter aortic valve implantation: the FRANCE-2 registry. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.1941] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Mean gradient (MG) elevation can be detected immediately post-procedure or secondarily during follow-up. Comparison between these two parameters and impact on outcomes has not previously been investigated.
Objectives
The study aimed to identify incidence, influence on prognosis and parameters associated with immediate high post-procedural mean transvalvular gradient (PPMG) and delayed mean gradient increase (DMGI), in the FRANCE 2 (French Aortic National CoreValve and Edwards 2) registry.
Methods
The registry includes all consecutive symptomatic patients with severe aortic stenosis. Three groups were analyzed: 1) PPMG <20mmHg without DMGI >10 mmHg (control); 2) PPMG <20mmHg with DMGI >10 mmHg (group 1); 3) PPMG ≥20 mmHg (group 2).
Results
From January 2010 to January 2012, 4201 consecutive patients were prospectively enrolled in the registry. The control group comprised 2078 patients; the group 1, 131 patients; and the group 2, 144 patients. DMGI exceeded 10 mmHg in 5.6%, and was not associated with greater 4-year mortality than in control group (32.6% vs. 40.1%, p=0.27, respectively). PPMG was at least 20 mmHg in 6.1%, and was associated with higher 4-year mortality than in control group (48.7% versus 40.1%, p=0.005, respectively) (Figure 1). Two-thirds of patients with initial PPMG ≥20 mmHg had finally a MG <20 mmHg at 1 year, with mortality similar to controls (39.2% vs. 40.1%, p=0.73).
Conclusions
Patients with PPMG >20 mmHg 1 year post-TAVI had higher 4-year mortality than the general population of the registry, unlike patients with MG normalization at 1 year.
Figure 1
Funding Acknowledgement
Type of funding source: Public Institution(s). Main funding source(s): French National Society of Cardiology
Collapse
Affiliation(s)
- R Didier
- Hospital Cavale Blanche, department of cardiology, Brest, France
| | - F Le Ven
- Hospital Cavale Blanche, department of cardiology, Brest, France
| | | | - B Nasr
- Hospital Cavale Blanche, Vascular Surgery, Brest, France
| | - T Lefevre
- Jacques Cartier Private Hospital, Massy, France
| | | | - E Teiger
- Henri Mondor University Hospital Chenevier APHP, Creteil, France
| | - D Carrie
- Rangueil Hospital of Toulouse, Toulouse, France
| | - N Meneveau
- University of Besançon, Besancon, France
| | - S Ghostine
- Marie Lannelongue Hospital, Le Plessis Robinson, France
| | - G Souteyrand
- University Hospital Gabriel Montpied, Clermont-Ferrand, France
| | - T Cuisset
- Hospital La Timone of Marseille, Marseille, France
| | - H Le Breton
- Hospital Pontchaillou of Rennes, Rennes, France
| | - B Inug
- Bichat Hospital, University Paris-Diderot, INSERM-UMR1148, FACT French Alliance for Cardiovascular T, Paris, France
| | - M Gilard
- Hospital Cavale Blanche, department of cardiology, Brest, France
| |
Collapse
|
10
|
Chopard R, Jimenez D, Serzian G, Ecarnot F, Falvo N, Kalbacher E, Bonnet B, Capellier G, Schiele F, Bertoletti L, Monreal M, Meneveau N. Renal function improves mortality prediction in acute pulmonary embolism: results of a multicentre cohort study with external validation in the RIETE registry. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.2239] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Renal dysfunction may influence outcomes after pulmonary embolism (PE). We determined the incremental value of adding renal function impairment (estimated glomerular filtration rate, eGFR <60 ml/min/1.73m2) on top of the 2019 ESC prognostic model, for the prediction of 30-day all-cause mortality in acute PE patients from a prospective, multicenter cohort.
Methods and results
We identified which of three eGFR formulae predicted death most accurately. Changes in global model fit, discrimination, calibration and net reclassification index (NRI) were evaluated with addition of eGFR. We prospectively included consecutive adult patients with acute PE diagnosed as per ESC guidelines. Among 1,943 patients, (mean age 67.3±17.1, 50.4% women), 107 (5.5% (95% CI 4.5–6.5%)) died during 30-day follow-up. The eGFRMDRD4 formula was the most accurate for prediction of death. The observed mortality rate was higher for intermediate-low risk (OR 1.8, 95% CI 1.1–3.4) and high-risk PE (OR 10.3, 95% CI 3.6–17.3), and 30-day bleeding was significantly higher (OR 2.1, 95% CI 1.3–3.5) in patients with vs without eGFRMDRD4 <60 ml/min/1.73m2. The addition of eGFRMDRD4 information improved model fit, discriminatory capacity, and calibration of the ESC models. NRI was significantly improved (p<0.001), with 18% reclassification of predicted mortality, specifically in intermediate and high-risk PE. External validation using data from the RIETE registry confirmed our findings (Table).
Conclusion
Addition of eGFRMDRD4-derived renal dysfunction on top of the ESC prognostic algorithm yields significant reclassification of risk of death in intermediate and high-risk PE. Impact on therapy remains to be determined.
Funding Acknowledgement
Type of funding source: Private grant(s) and/or Sponsorship. Main funding source(s): BMS-Pfizer Alliance, Bayer Healthcare
Collapse
Affiliation(s)
- R Chopard
- University Hospital of Besancon, Besancon, France
| | - D Jimenez
- University Hospital Ramon y Cajal de Madrid, Respiratory Medicine, Madrid, Spain
| | - G Serzian
- University Hospital of Besancon, Besancon, France
| | - F Ecarnot
- University Hospital of Besancon, Besancon, France
| | - N Falvo
- University Hospital of Dijon, Dijon, France
| | - E Kalbacher
- University Hospital of Besancon, Besancon, France
| | - B Bonnet
- General Hospital, Vesoul, France
| | - G Capellier
- University Hospital of Besancon, Besancon, France
| | - F Schiele
- University Hospital of Besancon, Besancon, France
| | - L Bertoletti
- University Hospital of Saint-Etienne, Saint-Etienne, France
| | - M Monreal
- Germans Trias i Pujol Hospital, Badalona, Spain
| | - N Meneveau
- University Hospital of Besancon, Besancon, France
| |
Collapse
|
11
|
Soumagne T, Winiszewski H, Besch G, Mahr N, Senot T, Costa P, Grillet F, Behr J, Mouhat B, Mourey G, Fournel A, Meneveau N, Samain E, Capellier G, Piton G, Pili-Floury S. Pulmonary embolism among critically ill patients with ARDS due to COVID-19. Respir Med Res 2020; 78:100789. [PMID: 33022510 PMCID: PMC7494436 DOI: 10.1016/j.resmer.2020.100789] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2020] [Revised: 08/25/2020] [Accepted: 08/31/2020] [Indexed: 02/06/2023]
Affiliation(s)
- T Soumagne
- Medical Intensive Care Unit, Besançon University Hospital, Besançon, France.
| | - H Winiszewski
- Medical Intensive Care Unit, Besançon University Hospital, Besançon, France
| | - G Besch
- Anaesthesiology and Surgical Intensive Care Unit, Besançon University Hospital, Besançon, France
| | - N Mahr
- Medical Intensive Care Unit, Besançon University Hospital, Besançon, France
| | - T Senot
- Anaesthesiology and Surgical Intensive Care Unit, Besançon University Hospital, Besançon, France
| | - P Costa
- Surgical and Medical Vascular Unit, Besançon University Hospital, Besançon, France
| | - F Grillet
- Department of Radiology, Besançon University Hospital, Besançon, France
| | - J Behr
- Department of Radiology, Besançon University Hospital, Besançon, France
| | - B Mouhat
- Cardiology Unit, Besançon University Hospital, Besançon, France
| | - G Mourey
- Hematology Unit, Besançon University Hospital, Besançon, France
| | - A Fournel
- Hematology Unit, Besançon University Hospital, Besançon, France
| | - N Meneveau
- Cardiology Unit, Besançon University Hospital, Besançon, France
| | - E Samain
- Anaesthesiology and Surgical Intensive Care Unit, Besançon University Hospital, Besançon, France
| | - G Capellier
- Medical Intensive Care Unit, Besançon University Hospital, Besançon, France
| | - G Piton
- Medical Intensive Care Unit, Besançon University Hospital, Besançon, France
| | - S Pili-Floury
- Anaesthesiology and Surgical Intensive Care Unit, Besançon University Hospital, Besançon, France
| |
Collapse
|
12
|
Chaux R, Sanchez O, Couturaud F, Meneveau N, Chopard R, Mismetti P, Laporte S, Ollier E. Association between initial and residual pulmonary vascular obstruction and pulmonary embolism recurrence, a pooled analysis. Rev Epidemiol Sante Publique 2020. [DOI: 10.1016/j.respe.2020.03.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
13
|
Eveno C, Chopard R, Meneveau N, Schiele F. Early prescription of direct oral anticoagulants for acute intermediate-high risk pulmonary embolism. Archives of Cardiovascular Diseases Supplements 2020. [DOI: 10.1016/j.acvdsp.2019.09.409] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
14
|
Guillon B, Moris M, Besutti M, Lefrancois Y, Amabile N, Combaret N, Ohlmann P, Belle L, Silvain J, Schiele F, Meneveau N. 5032Evaluation of the EAPCI OCT criteria for optimization of angioplasty in the DOCTORS study population. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
The recent expert consensus of the EAPCI suggested OCT criteria for the optimization of PCT after stent implantation. Using the data from the randomized, controlled DOCTORS study, we aimed to analyze the proportion of OCT criteria that were met immediately after stent implantation, and to evaluate the changes made to the revascularization strategy in order to optimize the procedure.
Methods
The DOCTORS study population consisted of patients admitted for non ST elevation myocardial infarction (NSTEMI) and presenting an indication for PCI with stent implantation of the target lesion. In the 120 patients randomized to the OCT-guided group, OCT was performed after initial coronary angiography and repeated immediately after stent implantation. The operator was required to evaluate quantitative measures of the reference diameter and reference area of the vessel and the length of the lesion based on the OCT images acquired before PCI. All OCT images were analyzed in a centralized core laboratory by 2 independent operators blinded to the angiographic findings. Post-PCI optimization targets to be achieved following stent implantation included optimal stent expansion (minimal stent area (MSA)/average reference lumen >80%), avoidance of landing zone in plaque burden >50% or lipid rich tissue; avoidance of large malapposition regions (axial distance <0.4 mm and <1 mm length), no extensive irregular tissue protrusion, and limited dissections (<60°, flap limited to intima, <2 mm length).
Results
Among the 120 patients who had an OCT run performed immediately after stent implantation, 50 patients (42%) had stent under-expansion, 59 (49%) had landing zone in plaque burden >50% or lipid rich tissue, 27 (22.5%) had stent malapposition, 25 (20.8%) had extensive irregular tissue protrusion and 45 (37.5%) had extensive edge dissection. Only 2 patients (1.7%) fullfiled all criteria of post-PCI optimization immediately after stent implantation, while no criterion was reached in 15 patients (12.5%). Post-stent overdilation was performed in all patients with stent underexpansion, and in 22/27 patients (81.5%) with stent malapposition. Additional stent implantation was performed in 32 patients (24 for landing zone in plaque burden >50% and 8 for extensive adventitial edge dissection). Overall, the use of OCT led the operator to optimize the procedural strategy in 60 patients (50%).
Conclusion
The proportion of suboptimal results as evaluated by OCT and based on the EAPCI criteria immediately after stent implantation was very high in the DOCTORS study, even though the choice of stent in these patients was based on pre-PCI OCT data. The post-PCI OCT findings led to a change of strategy to optimize the procedure in 50% of patients. It remains to be determined through a larger prospective study whether this optimization of PCI strategy is associated with a clinical benefit in the long term.
Collapse
Affiliation(s)
- B Guillon
- University Hospital of Besancon - Hospital Jean Minjoz, Besancon, France
| | - M Moris
- University Hospital of Besancon - Hospital Jean Minjoz, Besancon, France
| | - M Besutti
- University Hospital of Besancon - Hospital Jean Minjoz, Besancon, France
| | - Y Lefrancois
- Hospital Belfort-Montbeliard, Montbeliard, France
| | - N Amabile
- Institut Mutualiste Montsouris, Paris, France
| | - N Combaret
- University Hospital Gabriel Montpied, Clermont-Ferrand, France
| | - P Ohlmann
- University Hospital of Strasbourg, Strasbourg, France
| | - L Belle
- Hospital of Annecy, Annecy, France
| | - J Silvain
- Hospital Pitie-Salpetriere, Paris, France
| | - F Schiele
- University Hospital of Besancon - Hospital Jean Minjoz, Besancon, France
| | - N Meneveau
- University Hospital of Besancon - Hospital Jean Minjoz, Besancon, France
| |
Collapse
|
15
|
Chopard R, Serzian G, Humbert S, Falvo N, Morel-Aleton M, Bonnet B, Kalbacher E, Obert L, Capellier G, Cottin Y, Schiele F, Meneveau N. P2767Outcomes and incremental prognostic value of renal function impairment after acute pulmonary embolism. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz748.1084] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
We explored the relation between adverse outcomes after acute pulmonary embolism (PE)and renal dysfunction classified by estimated glomerular filtration rate (eGFR) using the CKD-EPI equation. We assessed the incremental value of adding eGFR CKD-EPI to the ESC score for predicting 30d mortality.
Methods
Prospective, multicenter study of 1664 acute PE admitted from 01/2011 to 12/2017. Pts were categorized in 4 eGFR groups: Group 1 (eGFR ≥60 ml/min/1.73m2, n=1178), group 2 (45–59; n=257); group 3 (30–44; n=150), group 4 (≤29; n=79).
Results
All-cause and CV death at 30 days and 6 months were higher in group 3 (p=0.005 and p=0.03) and group 4 (p<0.001 and p<0.001 respectively) vs group 1. Major bleeding at 30d and 6m was higher in group 2 vs group 1 (p=0.003 for both). Renal dysfunction combined with the ESC prognostic algorithm for prediction of 30d death improved discriminatory capacity of the model and enabled reclassification in different risk categories in 27% of pts (Table).
Without eGFR CKD-EPI OR (95% CI) With eGFR CKD-EPI OR (95% CI) ESC algorithm 2.59 (1.95–3.43) 2.30 (1.72–3.07) eGFR CKD-EPI – 2.60 (1.62–4.7) Measures of fit Bayes information criterion 607.30 599.32 Akaike information criterion 596.47 583.06 C-statistic 0.71* 0.77* P (Hosmer-Lemeshow) 0.057 0.43 Integrated discrimination improvement – 0.054 (0.052–0.056) Net reclassification improvement – 0.93 (0.90–0.95) Prognostic performance Sensitivity 62.5 (51.2–72.3) 76.2 (61.5–90.2) Specificity 64.2 (49.1–74.4) 69.9 (47.6–83.5) Positive predictive value 10.1 (8.2–11.3) 16.2 (14.2–18.2) Negative predictive value 0.97 (0.96–0.98) 98.1 (97.2–99.2) Positive likelihood ratio 1.96 (1.12–3.41) 2.12 (1.54–3.12) Negative likelihood ratio 0.50 (0.25–1.81) 0.54 (0.20–1.56) Youden index 0.31 (0.28–0.34) 0.39 (0.36–0.41) Difference in C-statistic: *p=0.04.
Conclusion
Renal function impairment increases the rate of adverse events after acute PE. Combined with the ESC early mortality risk score, eGFR improves risk classification.
Collapse
Affiliation(s)
- R Chopard
- University Hospital of Besancon, Besancon, France
| | - G Serzian
- University Hospital of Besancon, Besancon, France
| | - S Humbert
- University Hospital of Besancon, Besancon, France
| | - N Falvo
- University Hospital of Dijon, Dijon, France
| | | | - B Bonnet
- General Hospital, Vesoul, France
| | - E Kalbacher
- University Hospital of Besancon, Besancon, France
| | - L Obert
- University Hospital of Besancon, Besancon, France
| | - G Capellier
- University Hospital of Besancon, Besancon, France
| | - Y Cottin
- University Hospital of Dijon, Dijon, France
| | - F Schiele
- University Hospital of Besancon, Besancon, France
| | - N Meneveau
- University Hospital of Besancon, Besancon, France
| |
Collapse
|
16
|
Mouillet G, Fritzsch J, Thiery-Vuillemin A, Meneveau N, Almotlak H, Mansi L, Curtit E, Kim S, Jary M, Maurina T, Eberst G, Barthelemy P, Eymard JC, Geoffrois L, Djoumakh O, Anota A, Adotevi O, Westeel V, Paget-Bailly S. Physicians’ satisfaction with health-related quality of life (HRQoL) assessment in daily clinical practice using electronic patient-reported outcome (ePRO) for cancer patients. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz265.035] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
17
|
Meneveau N, Sanchez O. [How to estimate the prognosis of a pulmonary embolism?]. Rev Mal Respir 2019; 38 Suppl 1:e32-e40. [PMID: 31585779 DOI: 10.1016/j.rmr.2019.05.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Affiliation(s)
- N Meneveau
- F-CRIN INNOVTE, 42055 St-Étienne cedex 2, France; Service de cardiologie, CHU Jean-Minjoz, EA3920, université de Bourgogne-Franche Comté, boulevard Fleming, 25030 Besançon cedex, France
| | - O Sanchez
- F-CRIN INNOVTE, 42055 St-Étienne cedex 2, France; Université de Paris, Service de pneumologie et soins intensifs, AH-HP, hôpital Européen Georges-Pompidou, 75015 Paris, France; Innovations Thérapeutiques en Hémostase, INSERM UMRS 1140, 75006 Paris, France.
| |
Collapse
|
18
|
Schiele F, Puymirat E, Ferrieres J, Onceanu S, Beard T, Marchand X, Landel J, Meneveau N, Simon T, Danchin N. 468Patients eligible for proprotein convertase subtilisin/kexin type9 inhibitors (pcsk9i) after acute myocardial infarction. The ESC position applied to patients included in the FAST-MI 2015 registry. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz747.0126] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
PCSK9i on top of high intensity statins have shown clinical benefit in patients after Acute Myocardial Infarction (AMI) who are not at LDL-c target. The ESC Task Force has defined guidance for the prescription of PCSK9i. Among patients discharged after AMI, the rate of those eligible for PCSCK9i is poorly documented.
Methods
We used data from the nationwide French FAST-MI 2015 registry. PSCK9-eligible patients were defined as those discharged with high intensity statins with expected-LDL>140 mg/dL, or >100mg/dL if they had additional high risk features such as diabetes with renal dysfunction or hypertension, multivessel coronary disease, associated peripheral artery disease or recurrent MI. The expected LDL-c was estimated from admission LDL-c and changes in lipid-lowering treatment. The rate of eligible patients was estimated from actual treatment and optimized treatment (i.e. addition of ezetimibe).
Results
Among 5291 pts included, 4715 (89%) were discharged with statins, at high intensity in 3655 (71%). Expected LDL was 71mg/dL (IQ 56, 95). Among patients discharged with high intensity statins, 3146 (59%) had an expected LDL-c<100/mg (figure, in green). PCSK9-eligible patients were those with LDL-c>140mg/dL (n=178, 3.3%, in red) and, among those with LDL-c 100–140mg/dL (n=331, 6.2%, in yellow), patients who had additional risk features (n=227 (4%)). As a result, the population eligible for PSCK9i according to the ESC guidance would represent 7.6% (405 pts) of the population admitted with AMI. Expanding the indication to patients with statins, but not at high intensity would add 159 (3%). Conversely, optimizing discharge treatment with ezetimibe would reduce the rate of eligible patients to 3% (181 pts, in brown).
Conclusions
In real life, according to the ESC Task Force, 7.6% of the whole population admitted for AMI would be eligible for PCK9i. This rate could be reduced to 3% with the addition of ezetimibe.
Collapse
Affiliation(s)
- F Schiele
- University Hospital of Besancon, Besancon, France
| | - E Puymirat
- European Hospital Georges Pompidou, Paris, France
| | - J Ferrieres
- Toulouse Rangueil University Hospital (CHU), Toulouse, France
| | | | - T Beard
- Polyclinique de l'Ormeau, Tarbes, France
| | - X Marchand
- Hospital Poissy-St Germain en Laye, Poissy, France
| | - J Landel
- Hospital Saint Philibert, Lomme, France
| | - N Meneveau
- University Hospital of Besancon, Besancon, France
| | - T Simon
- Hospital Saint-Antoine, Paris, France
| | - N Danchin
- European Hospital Georges Pompidou, Paris, France
| |
Collapse
|
19
|
Guillon BG, Rubimbura VR, Fournier SF, Amabile NA, Chi Pan CCP, Combaret NC, Eeckhout EE, Silvain JS, Wijns W, Schiele F, Muller O, Meneveau N, Adjedj J. P1250Validation of quantitative flow reserve and residual quantitative flow reserve to predict fractional flow reserve post stenting from the DOCTORS study population. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz748.0208] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Quantitative flow reserve (QFR) is a computation of fractional flow reserve (FFR) based on angiography without use of a pressure wire. The ability to predict post-PCI FFR using residual QFR after virtual stenting (pre-PCI), and using QFR (post-PCI) remains unknown. We sought to evaluate the correlation and diagnosis accuracy of residual QFR and post-PCI QFR to predict post-PCI FFR.
Methods
From the DOCTORS (Does Optical Coherence Tomography Optimize Results of Stenting) study population, we blindly analyzed the following from angiography, and compared them to post-PCI FFR: pre-PCI residual contrast QFR (cQFR) and fixed QFR (fQFR), and post-PCI cQFR and fQFR.
Results
93 post-PCI QFR measurements and 84 residual QFR measurements were compared to post-PCI FFR measurements in 93 patients. Compared to the post-PCI FFR mean value of 0.92±0.05, mean values of residual cQFR, residual fQFR, post-PCI cQFR and post-PCI fQFR were, respectively: 0.94±0.05, 0.93±0.05, 0.93±0.06 and 0.93±0.05 (p values >0.05 for all pairs except for residual cQFR versus FFR (p=0.01)). Pearson correlation coefficients of residual cQFR, residual fQFR, post-PCI cQFR and post-PCI fQFR compared with post-PCI FFR were, respectively: 0.62, (95% CI: 0.46–0.73); 0.61, (95% CI: 0.45–0.73); 0.75, (95% CI: 0.64–0.83) and 0.73, (95% CI: 0.62–0.81). Area under the curves for these indices with a post-PCI FFR cutoff value of 0.90 were, respectively: 0.79, 0.78, 0.85 and 0.84.
Conclusions
cQFR and fQFR correlated well and had similar diagnostic performance. Pre-PCI QFR analysis with virtual PCI, and post-PCI QFR analysis, correlated well with post-PCI FFR, and had similar diagnostic accuracy. Further studies are needed to prospectively validate a QFR-guided PCI strategy.
Collapse
Affiliation(s)
- B G Guillon
- Regional University Hospital Jean Minjoz, Besancon, France
| | - V R Rubimbura
- University Hospital Centre Vaudois (CHUV), Lausanne, Switzerland
| | - S F Fournier
- University Hospital Centre Vaudois (CHUV), Lausanne, Switzerland
| | - N A Amabile
- Institut Mutualiste Montsouris, Paris, France
| | - C C P Chi Pan
- University Hospital Centre Vaudois (CHUV), Lausanne, Switzerland
| | - N C Combaret
- University Hospital Gabriel Montpied, Clermont-Ferrand, France
| | - E E Eeckhout
- University Hospital Centre Vaudois (CHUV), Lausanne, Switzerland
| | | | - W Wijns
- National University of Ireland, Galway, Ireland
| | - F Schiele
- Regional University Hospital Jean Minjoz, Besancon, France
| | - O Muller
- University Hospital Centre Vaudois (CHUV), Lausanne, Switzerland
| | - N Meneveau
- Regional University Hospital Jean Minjoz, Besancon, France
| | - J Adjedj
- University Hospital Centre Vaudois (CHUV), Lausanne, Switzerland
| |
Collapse
|
20
|
Chopard R, Andarelli JN, Humbert S, Falvo N, Morel-Aleton M, Bonnet B, Napporn G, Kalbacher E, Obert L, Degano B, Capellier G, Cottin Y, Schiele F, Meneveau N. Efficacy and safety of direct oral anticoagulants in intermediate-high risk pulmonary embolism: Results from a multidisciplinary multicenter prospective registry. Archives of Cardiovascular Diseases Supplements 2019. [DOI: 10.1016/j.acvdsp.2019.01.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
21
|
Brower J, Sterling K, Goldhaber S, Konstantinides S, Meneveau N, Tapson V, Kucher N. Abstract No. 602 Rationale and experimental design of the KNOCOUT PE trial: an international EKoSoNic® registry of the treatment and clinical outcomes of patients with pulmonary embolism. J Vasc Interv Radiol 2019. [DOI: 10.1016/j.jvir.2018.12.683] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
22
|
Sanchez O, Benhamou Y, Bertoletti L, Constant J, Couturaud F, Delluc A, Elias A, Fischer AM, Frappé P, Gendron N, Girard P, Godier A, Gut-Gobert C, Laporte S, Mahé I, Mauge L, Meneveau N, Meyer G, Mismetti P, Parent F, Pernod G, Quéré I, Revel MP, Roy PM, Salaün PY, Smadja DM, Sevestre MA. [Recommendations of good practice for the management of thromboembolic venous disease in adults. Short version]. Rev Mal Respir 2019; 36:249-283. [PMID: 30799126 DOI: 10.1016/j.rmr.2019.01.003] [Citation(s) in RCA: 55] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Affiliation(s)
- O Sanchez
- INSERM UMRS 1140, Université Paris Descartes, Sorbonne Paris Cité, Service de Pneumologie et de soins intensifs, hôpital Européen Georges-Pompidou, Assistance publique des Hôpitaux de Paris, 75015 Paris, France; F-CRIN INNOVTE, 42055 St-Étienne cedex 2, France.
| | - Y Benhamou
- Normandie université UNI Rouen U1096, service de médecine interne, CHU Charles Nicolle, 76000 Rouen, France
| | - L Bertoletti
- F-CRIN INNOVTE, 42055 St-Étienne cedex 2, France; INSERM UMR1059, Équipe dysfonction vasculaire et hémostase, service de médecine vasculaire et thérapeutique, CHU de St-Étienne, Université Jean-Monnet, INSERM, CIC-1408, 42000 Saint-Étienne, France
| | - J Constant
- Service de médecine vasculaire, hôpital St-André, université de Bordeaux, 33000 Bordeaux, France
| | - F Couturaud
- F-CRIN INNOVTE, 42055 St-Étienne cedex 2, France; Département de médecine interne et pneumologie, EA3878-GETBO, CIC_INSERM1412, université de Bretagne occidentale, centre hospitalo-universitaire de Brest, 29200 Brest, France
| | - A Delluc
- F-CRIN INNOVTE, 42055 St-Étienne cedex 2, France; EA 3878 GETBO, université de Bretagne occidentale, 29200 Brest, France
| | - A Elias
- F-CRIN INNOVTE, 42055 St-Étienne cedex 2, France; Département de médecine vasculaire, hôpital Sainte-Musse, 83100 Toulon, France
| | - A-M Fischer
- F-CRIN INNOVTE, 42055 St-Étienne cedex 2, France; Université Paris Descartes, Sorbonne Paris Cité, service d'hématologie biologique hôpital Européen Georges-Pompidou, Assistance publique des Hôpitaux de Paris, 75015 Paris, France
| | - P Frappé
- Inserm UMR 1059 Sainbiose DVH, Inserm CIC-EC 1408, département de médecine générale, université de Saint-Étienne, 42000 St-Étienne, France
| | - N Gendron
- INSERM UMR 1148, Université Paris Diderot, Sorbonne Paris Cité, laboratoire d'hématologie, hôpital Bichat-Claude Bernard, AP-HP, 75018 Paris, France
| | - P Girard
- Institut du Thorax-Curie-Montsouris, l'institut Mutualiste Montsouris, 75014 Paris, France
| | - A Godier
- INSERM UMRS 1140, service d'anesthésie réanimation, hôpital Européen Georges-Pompidou, AP-HP, 75015 Paris, France
| | - C Gut-Gobert
- F-CRIN INNOVTE, 42055 St-Étienne cedex 2, France; Département de médecine interne et pneumologie, EA3878-GETBO, CIC_INSERM1412, université de Bretagne occidentale, centre hospitalo-universitaire de Brest, 29200 Brest, France
| | - S Laporte
- F-CRIN INNOVTE, 42055 St-Étienne cedex 2, France; INSERM, unité de Recherche Clinique, SAINBOIS U1059 équipe DVH, université Jean-Monnet, université de Lyon, Innovation, Pharmacologie, CHU Saint-Étienne, hôpital Nord, 42000 Saint-Étienne, France
| | - I Mahé
- F-CRIN INNOVTE, 42055 St-Étienne cedex 2, France; Université Paris 7, Service de Médecine Interne-Hôpital Louis-Mourier, Assistance Publique des Hôpitaux de Paris, 92700 Colombes, France; Inserm UMR_S1140, 75006 Paris, France
| | - L Mauge
- UMR-S 970, PARCC (Paris-Cardiovascular Research Center), Université Paris Descartes, Sorbonne Paris Cité, Service d'Hématologie biologique, Hôpital Européen Georges Pompidou, Assistance Publique Hôpitaux de Paris, 75015 Paris, France
| | - N Meneveau
- F-CRIN INNOVTE, 42055 St-Étienne cedex 2, France; Service de cardiologie, CHU Jean Minjoz Boulevard Fleming ; EA3920, Université de Bourgogne-Franche Comté, 25030 Besançon cedex, France
| | - G Meyer
- F-CRIN INNOVTE, 42055 St-Étienne cedex 2, France; INSERM UMRS 970 ; INSERM CIC 1418, université Paris Descartes, Sorbonne Paris Cité, service de pneumologie et de soins intensifs, hôpital Européen Georges-Pompidou, Assistance publique des Hôpitaux de Paris, 75015 Paris, France
| | - P Mismetti
- F-CRIN INNOVTE, 42055 St-Étienne cedex 2, France; INSERM, SAINBOIS U1059 équipe DVH, université Jean-Monnet, université de Lyon, Unité de Recherche Clinique, Innovation, Pharmacologie, et service de médecine vasculaire et thérapeutique, CHU Saint-Étienne, Hôpital Nord, 42000 Saint-Étienne, France
| | - F Parent
- Université Paris-Sud, faculté de médecine, université Paris-Saclay, service de pneumologie, centre de référence de l'hypertension pulmonaire, hôpital Bicêtre, AP-HP, 94270 Le Kremlin Bicêtre, France; INSERM UMR_S 999, hôpital Marie-Lannelongue, 92350 Le Plessis Robinson, France
| | - G Pernod
- F-CRIN INNOVTE, 42055 St-Étienne cedex 2, France; Service universitaire de médecine vasculaire, CHU Grenoble, université Grenoble Alpes CNRS/TIMC-IMAG UMR 5525/Thèmas, 38700 La Tronche, France
| | - I Quéré
- F-CRIN INNOVTE, 42055 St-Étienne cedex 2, France; Département de médecine vasculaire, centre de référence des maladies vasculaires rares, EA2992, université de Montpellier, CHU Montpellier, hôpital Saint-Éloi, 34295 Montpellier cedex 5, France
| | - M-P Revel
- Université Paris Descartes, Sorbonne Paris Cité, service de radiologie A, hôpital Cochin, Assistance publique des Hôpitaux de Paris, 75014 Paris, France
| | - P-M Roy
- F-CRIN INNOVTE, 42055 St-Étienne cedex 2, France; Département de médecine d'urgence et service de médecine vasculaire, CHU Angers, 49000 Angers, France; Institut Mitovasc, UMR 1083, UFR Santé, université d'Angers, 49000 Angers, France
| | - P-Y Salaün
- INSERM EA3878 (GETBO), service de médecine nucléaire, CHRU de BREST, université de Bretagne occidentale, 29200 Brest, France
| | - D M Smadja
- F-CRIN INNOVTE, 42055 St-Étienne cedex 2, France; INSERM UMR-S1140, université Paris Descartes, Sorbonne Paris Cité, hôpital Européen Georges-Pompidou, service d'hématologie, AP-HP, hôpital Européen Georges-Pompidou, laboratoire de recherche biochirurgicale, Fondation Carpentier, 75015 Paris, France
| | - M-A Sevestre
- F-CRIN INNOVTE, 42055 St-Étienne cedex 2, France; Service de médecine vasculaire, EA 7516 Chimère, CHU Amiens, 80080 Amiens, France
| |
Collapse
|
23
|
Yahia MC, Braik N, Amabile N, Souteyrand G, Ohlmann P, Lefrançois Y, Silvain J, Schiele F, Meneveau N. Intracoronary thrombus by Optical Coherence Tomography (OCT): Characterization, quantification and prognostic impact in patients with non-ST-elevation acute coronary syndrome. A DOCTORS substudy. Archives of Cardiovascular Diseases Supplements 2019. [DOI: 10.1016/j.acvdsp.2018.10.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
24
|
Curtit E, Bazan F, Chaigneau L, Mouillet G, Dobi E, Mansi L, Meneveau N, Paillard MJ, Meynard G, Klajer E, Villanueva C, Montcuquet P, Pivot X, Cals L. Prolonged overall survival for patients with bone-only metastases at presentation of metastatic breast cancer. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy272.347] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
25
|
Klajer E, Paget-Bailly S, Meynard G, Meurisse A, Bazan F, Chaigneau L, Dobi E, Meneveau N, Montcuquet P, Villanueva C, Thiery-Vuillemin A, Kalbacher E, Populaire C, Collonge-Rame MA, Gligorov J, Curtit E, Pivot X, Mansi L. Impact of BRCA status on outcomes and survival in high-risk early breast cancers. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy270.207] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
26
|
Schiele F, Simon T, Puymirat E, Cayla G, Gerbaud E, Ohlmann P, Popovic B, Bresson D, Farah B, Ferrieres J, Meneveau N, Danchin N. P832Temporal changes in quality of care for acute myocardial infarction and relation with 1 year survival: acute cardiac care association quality indicators applied to the FAST-MI registries. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy564.p832] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- F Schiele
- University Hospital of Besancon, Besancon, France
| | - T Simon
- Hospital Saint-Antoine, Paris, France
| | - E Puymirat
- European Hospital Georges Pompidou, Paris, France
| | - G Cayla
- University Hospital of Nimes, Nimes, France
| | - E Gerbaud
- Hospital Haut Leveque, Bordeaux-Pessac, France
| | - P Ohlmann
- University Hospital of Strasbourg, Strasbourg, France
| | - B Popovic
- Hospital Brabois of Nancy, Vandoeuvre les Nancy, France
| | - D Bresson
- Hospital Emile Muller, Mulhouse, France
| | - B Farah
- Clinic Pasteur of Toulouse, Toulouse, France
| | - J Ferrieres
- Toulouse Rangueil University Hospital (CHU), Toulouse, France
| | - N Meneveau
- University Hospital of Besancon, Besancon, France
| | - N Danchin
- European Hospital Georges Pompidou, Paris, France
| |
Collapse
|
27
|
Chopard R, Serzian G, Humbert S, Falvo N, Morel-Aleton M, Bonnet B, Napporn G, Kalbacher E, Obert L, Degano B, Capellier G, Cottin Y, Schiele F, Meneveau N. P3555Non-recommended dosing of direct oral anticoagulants in acute pulmonary embolism is related to an increased rate of adverse events at 6 months: results of a prospective regional multicenter registry. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p3555] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- R Chopard
- University Hospital of Besancon, Besancon, France
| | - G Serzian
- University Hospital of Besancon, Besancon, France
| | - S Humbert
- University Hospital of Besancon, Besancon, France
| | - N Falvo
- University Hospital of Dijon, Dijon, France
| | | | - B Bonnet
- General Hospital, Vesoul, France
| | - G Napporn
- Louis Pasteur Hospital, Dole, France
| | - E Kalbacher
- University Hospital of Besancon, Besancon, France
| | - L Obert
- University Hospital of Besancon, Besancon, France
| | - B Degano
- University Hospital of Besancon, Besancon, France
| | - G Capellier
- University Hospital of Besancon, Besancon, France
| | - Y Cottin
- University Hospital of Dijon, Dijon, France
| | - F Schiele
- University Hospital of Besancon, Besancon, France
| | - N Meneveau
- University Hospital of Besancon, Besancon, France
| |
Collapse
|
28
|
Meneveau N, Yahia M, Braik N, Bonnet B, Chopard R, Amabile N, Souteyrand G, Ohlmann P, Lefrancois Y, Silvain J, Schiele F. P825Evaluation of intracoronary thrombus by optical coherence tomography: characterization, quantification, prognostic impact in patients with non-ST-elevation acute coronary syndrome. A DOCTORS substudy. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy564.p825] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- N Meneveau
- University Hospital of Besancon - Hospital Jean Minjoz, Besancon, France
| | - M Yahia
- University Hospital of Besancon - Hospital Jean Minjoz, Besancon, France
| | - N Braik
- University Hospital of Besancon - Hospital Jean Minjoz, Besancon, France
| | - B Bonnet
- University Hospital of Besancon - Hospital Jean Minjoz, Besancon, France
| | - R Chopard
- University Hospital of Besancon - Hospital Jean Minjoz, Besancon, France
| | - N Amabile
- Institut Mutualiste Montsouris, Paris, France
| | - G Souteyrand
- University Hospital Gabriel Montpied, Clermont-Ferrand, France
| | - P Ohlmann
- University Hospital of Strasbourg, Strasbourg, France
| | | | - J Silvain
- Hospital Pitie-Salpetriere, Paris, France
| | - F Schiele
- University Hospital of Besancon - Hospital Jean Minjoz, Besancon, France
| |
Collapse
|
29
|
Chopard R, Cart L, Humbert S, Falvo N, Morel-Aleton M, Bonnet B, Napporn G, Kalbacher E, Obert L, Degano B, Capellier G, Cottin Y, Schiele F, Meneveau N. P255Prognostic impact of non-compliance with guidelines-recommended treatment of acute pulmonary embolism: Results of a prospective multicenter registry. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy564.p255] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- R Chopard
- University Hospital of Besancon, Besancon, France
| | - L Cart
- University Hospital of Besancon, Besancon, France
| | - S Humbert
- University Hospital of Besancon, Besancon, France
| | - N Falvo
- University Hospital of Dijon, Dijon, France
| | | | - B Bonnet
- General Hospital, Vesoul, France
| | - G Napporn
- Louis Pasteur Hospital, Dole, France
| | - E Kalbacher
- University Hospital of Besancon, Besancon, France
| | - L Obert
- University Hospital of Besancon, Besancon, France
| | - B Degano
- University Hospital of Besancon, Besancon, France
| | - G Capellier
- University Hospital of Besancon, Besancon, France
| | - Y Cottin
- University Hospital of Dijon, Dijon, France
| | - F Schiele
- University Hospital of Besancon, Besancon, France
| | - N Meneveau
- University Hospital of Besancon, Besancon, France
| |
Collapse
|
30
|
Schiele F, Simon T, Puymirat E, Cayla G, Gerbaud E, Ohlmann P, Popovic B, Bresson D, Farah B, Ferrieres J, Meneveau N, Danchin N, Lemesle G, Martinet M. P973Impact of existing or new-onset atrial fibrillation in a setting of acute myocardial infarction. Insights from the FAST-MI 2005, 2010 and 2015 registries. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy564.p973] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- F Schiele
- University Hospital of Besancon, Besancon, France
| | - T Simon
- Hospital Saint-Antoine, Paris, France
| | - E Puymirat
- European Hospital Georges Pompidou, Paris, France
| | - G Cayla
- University Hospital of Nimes, Nimes, France
| | - E Gerbaud
- Hospital Haut Leveque, Bordeaux-Pessac, France
| | - P Ohlmann
- University Hospital of Strasbourg, Strasbourg, France
| | - B Popovic
- Hospital Brabois of Nancy, Vandoeuvre les Nancy, France
| | - D Bresson
- Hospital Emile Muller, Mulhouse, France
| | - B Farah
- Clinic Pasteur of Toulouse, Toulouse, France
| | - J Ferrieres
- Toulouse Rangueil University Hospital (CHU), Toulouse, France
| | - N Meneveau
- University Hospital of Besancon, Besancon, France
| | - N Danchin
- European Hospital Georges Pompidou, Paris, France
| | | | - M Martinet
- European Hospital Georges Pompidou, Paris, France
| |
Collapse
|
31
|
Meneveau N, Capellier G, Blanquette B, Guillon B, Pili-Floury S, Kimmoun A, Gaide-Chevronnay L, Aissaoui N, Zogheib E, Ecarnot F, Schiele F, De Prost N, Girard P, Deye N, Sanchez O. P3556Extracorporeal membrane oxygenation in patients with pulmonary embolism. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p3556] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- N Meneveau
- University Hospital of Besancon - Hospital Jean Minjoz, Besancon, France
| | - G Capellier
- University Hospital of Besancon - Hospital Jean Minjoz, Besancon, France
| | - B Blanquette
- European Hospital Georges Pompidou, Paris, France
| | - B Guillon
- University Hospital of Besancon - Hospital Jean Minjoz, Besancon, France
| | - S Pili-Floury
- University Hospital of Besancon - Hospital Jean Minjoz, Besancon, France
| | - A Kimmoun
- Hospital Brabois of Nancy, Vandoeuvre les Nancy, France
| | | | - N Aissaoui
- European Hospital Georges Pompidou, Paris, France
| | - E Zogheib
- University Hospital of Amiens, Amiens, France
| | - F Ecarnot
- University Hospital of Besancon - Hospital Jean Minjoz, Besancon, France
| | - F Schiele
- University Hospital of Besancon - Hospital Jean Minjoz, Besancon, France
| | - N De Prost
- University Hospital Henri Mondor, Creteil, France
| | - P Girard
- Institut Mutualiste Montsouris, Paris, France
| | - N Deye
- Hospital Lariboisiere, Paris, France
| | - O Sanchez
- European Hospital Georges Pompidou, Paris, France
| |
Collapse
|
32
|
Chopard R, Andarelli JN, Humbert S, Falvo N, Morel-Aleton M, Bonnet B, Napporn G, Kalbacher E, Obert L, Degano B, Capellier G, Cottin Y, Schiele F, Meneveau N. P3554Efficacy and safety of direct oral anticoagulants in intermediate-high risk pulmonary embolism: results from a multidisciplinary multicenter prospective registry. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p3554] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- R Chopard
- University Hospital of Besancon, Besancon, France
| | | | - S Humbert
- University Hospital of Besancon, Besancon, France
| | - N Falvo
- University Hospital of Dijon, Dijon, France
| | | | - B Bonnet
- General Hospital, Vesoul, France
| | - G Napporn
- Louis Pasteur Hospital, Dole, France
| | - E Kalbacher
- University Hospital of Besancon, Besancon, France
| | - L Obert
- University Hospital of Besancon, Besancon, France
| | - B Degano
- University Hospital of Besancon, Besancon, France
| | - G Capellier
- University Hospital of Besancon, Besancon, France
| | - Y Cottin
- University Hospital of Dijon, Dijon, France
| | - F Schiele
- University Hospital of Besancon, Besancon, France
| | - N Meneveau
- University Hospital of Besancon, Besancon, France
| |
Collapse
|
33
|
Kresoja KP, Meneveau N, Jimenez D, Sanchez O, Becattini C, Spillmann F, Sobkowicz B, Vanni S, Konstantinides S, Kurzyna M, Pruszczyk P, Wilkens H, Bova C, Meyer G, Lankeit M. 2163Predicting in-hospital major bleeding in pulmonary embolism patients treated with systemic thrombolytic therapy. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy565.2163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- K.-P Kresoja
- Charite - Campus Virchow-Klinikum (CVK), Cardiology, Berlin, Germany
| | - N Meneveau
- University Hospital Besancon, Department of Cardiology,, Besancon, France
| | - D Jimenez
- University Hospital del Henares, Respiratory Department, Instituto Ramόn y Cajal de Investigaciόn Sanitaria IRYCIS, Madrid, Spain
| | - O Sanchez
- University Paris-Descartes, Service de Pneumologie et de Soins Intensifs, Paris, France
| | - C Becattini
- University of Perugia, Medicina Interna e Cardiovascolare, Stroke Unit, Perugia, Italy
| | - F Spillmann
- Charite - Campus Virchow-Klinikum (CVK), Cardiology, Berlin, Germany
| | - B Sobkowicz
- Medical University of Bialystok, Department of Cardiology, Medical University of Bialystok, Bialystok, Poland
| | - S Vanni
- Careggi University Hospital (AOUC), Emergency Department, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
| | | | - M Kurzyna
- European Health Center, Department of Pulmonary Circulation and Thromboembolic Diseases, The Medical Centre of Postgraduate, Otwock, Poland
| | - P Pruszczyk
- Medical University of Warsaw, Department of Internal Medicine and Cardiology, Warsaw, Poland
| | - H Wilkens
- Saarland University Hospital, Pneumology, Homburg, Germany
| | - C Bova
- Ospedale SS Annunziata, Department of Medicine, Cosenza, Italy
| | - G Meyer
- Hôpital Européen Georges Pompidou, Université Paris Descartes, Dept of Respiratory Diseases, Paris, France
| | - M Lankeit
- Charite - Campus Virchow-Klinikum (CVK), Cardiology, Berlin, Germany
| |
Collapse
|
34
|
Schiele F, Simon T, Puymirat E, Cayla G, Gerbaud E, Ohlmann P, Popovic B, Bresson D, Farah B, Ferrieres J, Meneveau N, Danchin N. P4490Quality matters: classification of centres by quality of care in acute myocardial infarction using the ESC-Acute Cardiac Care Association quality indicators. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p4490] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- F Schiele
- University Hospital of Besancon, Besancon, France
| | - T Simon
- Hospital Saint-Antoine, Paris, France
| | - E Puymirat
- European Hospital Georges Pompidou, Paris, France
| | - G Cayla
- University Hospital of Nimes, Nimes, France
| | - E Gerbaud
- Hospital Haut Leveque, Bordeaux-Pessac, France
| | - P Ohlmann
- University Hospital of Strasbourg, Strasbourg, France
| | - B Popovic
- Hospital Brabois of Nancy, Vandoeuvre les Nancy, France
| | - D Bresson
- Hospital Emile Muller, Mulhouse, France
| | - B Farah
- Clinic Pasteur of Toulouse, Toulouse, France
| | - J Ferrieres
- Toulouse Rangueil University Hospital (CHU), Toulouse, France
| | - N Meneveau
- University Hospital of Besancon, Besancon, France
| | - N Danchin
- European Hospital Georges Pompidou, Paris, France
| |
Collapse
|
35
|
Guillon B, Marcucci C, Chatot M, Chopard R, Meneveau N, Genet B, Braik N, Schiele F. P4280Contemporary predictors of contrast-induced acute kidney injury. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx504.p4280] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
36
|
Bechiri M, Souteyrand G, Motreff P, Mangin L, Range G, Levesque S, Meneveau N, Lefevre T, Trouillet C, Caussin C, Amabile N. P2345Characteristics of stent thrombosis in bifurcation lesions analyzed by optical coherence tomography. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx502.p2345] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
37
|
Guillon B, Marcucci C, Chatot M, Chopard R, Meneveau N, Genet B, Braik N, Schiele F. P6446Impact of the definition used on incidence and prognosis of CI-AKI after coronary angiography for acute coronary syndromes. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx493.p6446] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
38
|
Guillon B, Piton G, Capellier G, Chatot M, Bonnet B, Pili-Floury S, Perrotti A, Chocron S, Schiele F, Meneveau N. P4247Veno-arterial extracorporeal membrane oxygenation in high risk pulmonary embolism. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx504.p4247] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
39
|
Rabani V, Montange D, Meneveau N, Davani S. P5370Impact of ticagrelor on P2Y1 and P2Y12 localization and on Cholesterol levels in platelet plasma membrane. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx493.p5370] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
40
|
Braik N, Bonnet B, Genet B, Chatot M, Chopard R, Seronde M, Schiele F, Meneveau N. Impact of plaque morphology as assessed by optical coherence tomography on procedural outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Archives of Cardiovascular Diseases Supplements 2017. [DOI: 10.1016/s1878-6480(17)30081-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
41
|
Targher G, Dauriz M, Laroche C, Temporelli PL, Hassanein M, Seferovic PM, Drozdz J, Ferrari R, Anker S, Coats A, Filippatos G, Crespo‐Leiro MG, Mebazaa A, Piepoli MF, Maggioni AP, Tavazzi L, Crespo‐Leiro M, Anker S, Coats A, Ferrari R, Filippatos G, Maggioni A, Mebazaa A, Piepoli M, Amir O, Chioncel O, Dahlström U, Jimenez JD, Drozdz J, Erglis A, Fazlibegovic E, Fonseca C, Fruhwald F, Gatzov P, Goncalvesova E, Hassanein M, Hradec J, Kavoliuniene A, Lainscak M, Logeart D, Merkely B, Metra M, Otljanska M, Seferovic P, Kostovska ES, Temizhan A, Tousoulis D, Andarala M, Ferreira T, Fiorucci E, Gracia G, Laroche C, Pommier C, Taylor C, Cuculici A, Gaulhofer C, Casado EP, Szymczyk E, Ramani F, Mulak G, Schou IL, Semenka J, Stojkovic J, Mehanna R, Mizarienne V, Auer J, Ablasser K, Fruhwald F, Dolze T, Brandner K, Gstrein S, Poelzl G, Moertl D, Reiter S, Podczeck‐Schweighofer A, Muslibegovic A, Vasilj M, Fazlibegovic E, Cesko M, Zelenika D, Palic B, Pravdic D, Cuk D, Vitlianova K, Katova T, Velikov T, Kurteva T, Gatzov P, Kamenova D, Antova M, Sirakova V, Krejci J, Mikolaskova M, Spinar J, Krupicka J, Malek F, Hegarova M, Lazarova M, Monhart Z, Hassanein M, Sobhy M, El Messiry F, El Shazly A, Elrakshy Y, Youssef A, Moneim A, Noamany M, Reda A, Dayem TA, Farag N, Halawa SI, Hamid MA, Said K, Saleh A, Ebeid H, Hanna R, Aziz R, Louis O, Enen M, Ibrahim B, Nasr G, Elbahry A, Sobhy H, Ashmawy M, Gouda M, Aboleineen W, Bernard Y, Luporsi P, Meneveau N, Pillot M, Morel M, Seronde M, Schiele F, Briand F, Delahaye F, Damy T, Eicher J, Groote P, Fertin M, Lamblin N, Isnard R, Lefol C, Thevenin S, Hagege A, Jondeau G, Logeart D, Le Marcis V, Ly J, Coisne D, Lequeux B, Le Moal V, Mascle S, Lotton P, Behar N, Donal E, Thebault C, Ridard C, Reynaud A, Basquin A, Bauer F, Codjia R, Galinier M, Tourikis P, Stavroula M, Tousoulis D, Stefanadis C, Chrysohoou C, Kotrogiannis I, Matzaraki V, Dimitroula T, Karavidas A, Tsitsinakis G, Kapelios C, Nanas J, Kampouri H, Nana E, Kaldara E, Eugenidou A, Vardas P, Saloustros I, Patrianakos A, Tsaknakis T, Evangelou S, Nikoloulis N, Tziourganou H, Tsaroucha A, Papadopoulou A, Douras A, Polgar L, Merkely B, Kosztin A, Nyolczas N, Nagy AC, Halmosi R, Elber J, Alony I, Shotan A, Fuhrmann AV, Amir O, Romano S, Marcon S, Penco M, Di Mauro M, Lemme E, Carubelli V, Rovetta R, Metra M, Bulgari M, Quinzani F, Lombardi C, Bosi S, Schiavina G, Squeri A, Barbieri A, Di Tano G, Pirelli S, Ferrari R, Fucili A, Passero T, Musio S, Di Biase M, Correale M, Salvemini G, Brognoli S, Zanelli E, Giordano A, Agostoni P, Italiano G, Salvioni E, Copelli S, Modena M, Reggianini L, Valenti C, Olaru A, Bandino S, Deidda M, Mercuro G, Dessalvi CC, Marino P, Di Ruocco M, Sartori C, Piccinino C, Parrinello G, Licata G, Torres D, Giambanco S, Busalacchi S, Arrotti S, Novo S, Inciardi R, Pieri P, Chirco P, Galifi MA, Teresi G, Buccheri D, Minacapelli A, Veniani M, Frisinghelli A, Priori S, Cattaneo S, Opasich C, Gualco A, Pagliaro M, Mancone M, Fedele F, Cinque A, Vellini M, Scarfo I, Romeo F, Ferraiuolo F, Sergi D, Anselmi M, Melandri F, Leci E, Iori E, Bovolo V, Pidello S, Frea S, Bergerone S, Botta M, Canavosio F, Gaita F, Merlo M, Cinquetti M, Sinagra G, Ramani F, Fabris E, Stolfo D, Artico J, Miani D, Fresco C, Daneluzzi C, Proclemer A, Cicoira M, Zanolla L, Marchese G, Torelli F, Vassanelli C, Voronina N, Erglis A, Tamakauskas V, Smalinskas V, Karaliute R, Petraskiene I, Kazakauskaite E, Rumbinaite E, Kavoliuniene A, Vysniauskas V, Brazyte‐Ramanauskiene R, Petraskiene D, Stankala S, Switala P, Juszczyk Z, Sinkiewicz W, Gilewski W, Pietrzak J, Orzel T, Kasztelowicz P, Kardaszewicz P, Lazorko‐Piega M, Gabryel J, Mosakowska K, Bellwon J, Rynkiewicz A, Raczak G, Lewicka E, Dabrowska‐Kugacka A, Bartkowiak R, Sosnowska‐Pasiarska B, Wozakowska‐Kaplon B, Krzeminski A, Zabojszcz M, Mirek‐Bryniarska E, Grzegorzko A, Bury K, Nessler J, Zalewski J, Furman A, Broncel M, Poliwczak A, Bala A, Zycinski P, Rudzinska M, Jankowski L, Kasprzak J, Michalak L, Soska KW, Drozdz J, Huziuk I, Retwinski A, Flis P, Weglarz J, Bodys A, Grajek S, Kaluzna‐Oleksy M, Straburzynska‐Migaj E, Dankowski R, Szymanowska K, Grabia J, Szyszka A, Nowicka A, Samcik M, Wolniewicz L, Baczynska K, Komorowska K, Poprawa I, Komorowska E, Sajnaga D, Zolbach A, Dudzik‐Plocica A, Abdulkarim A, Lauko‐Rachocka A, Kaminski L, Kostka A, Cichy A, Ruszkowski P, Splawski M, Fitas G, Szymczyk A, Serwicka A, Fiega A, Zysko D, Krysiak W, Szabowski S, Skorek E, Pruszczyk P, Bienias P, Ciurzynski M, Welnicki M, Mamcarz A, Folga A, Zielinski T, Rywik T, Leszek P, Sobieszczanska‐Malek M, Piotrowska M, Kozar‐Kaminska K, Komuda K, Wisniewska J, Tarnowska A, Balsam P, Marchel M, Opolski G, Kaplon‐Cieslicka A, Gil R, Mozenska O, Byczkowska K, Gil K, Pawlak A, Michalek A, Krzesinski P, Piotrowicz K, Uzieblo‐Zyczkowska B, Stanczyk A, Skrobowski A, Ponikowski P, Jankowska E, Rozentryt P, Polonski L, Gadula‐Gacek E, Nowalany‐Kozielska E, Kuczaj A, Kalarus Z, Szulik M, Przybylska K, Klys J, Prokop‐Lewicka G, Kleinrok A, Aguiar CT, Ventosa A, Pereira S, Faria R, Chin J, De Jesus I, Santos R, Silva P, Moreno N, Queirós C, Lourenço C, Pereira A, Castro A, Andrade A, Guimaraes TO, Martins S, Placido R, Lima G, Brito D, Francisco A, Cardiga R, Proenca M, Araujo I, Marques F, Fonseca C, Moura B, Leite S, Campelo M, Silva‐Cardoso J, Rodrigues J, Rangel I, Martins E, Correia AS, Peres M, Marta L, Silva GF, Severino D, Durao D, Leao S, Magalhaes P, Moreira I, Cordeiro AF, Ferreira C, Araujo C, Ferreira A, Baptista A, Radoi M, Bicescu G, Vinereanu D, Sinescu C, Macarie C, Popescu R, Daha I, Dan G, Stanescu C, Dan A, Craiu E, Nechita E, Aursulesei V, Christodorescu R, Otasevic P, Seferovic P, Simeunovic D, Ristic A, Celic V, Pavlovic‐Kleut M, Lazic JS, Stojcevski B, Pencic B, Stevanovic A, Andric A, Iric‐Cupic V, Jovic M, Davidovic G, Milanov S, Mitic V, Atanaskovic V, Antic S, Pavlovic M, Stanojevic D, Stoickov V, Ilic S, Ilic MD, Petrovic D, Stojsic S, Kecojevic S, Dodic S, Adic NC, Cankovic M, Stojiljkovic J, Mihajlovic B, Radin A, Radovanovic S, Krotin M, Klabnik A, Goncalvesova E, Pernicky M, Murin J, Kovar F, Kmec J, Semjanova H, Strasek M, Iskra MS, Ravnikar T, Suligoj NC, Komel J, Fras Z, Jug B, Glavic T, Losic R, Bombek M, Krajnc I, Krunic B, Horvat S, Kovac D, Rajtman D, Cencic V, Letonja M, Winkler R, Valentincic M, Melihen‐Bartolic C, Bartolic A, Vrckovnik MP, Kladnik M, Pusnik CS, Marolt A, Klen J, Drnovsek B, Leskovar B, Anguita MF, Page JG, Martinez FS, Andres J, Genis A, Mirabet S, Mendez A, Garcia‐Cosio L, Roig E, Leon V, Gonzalez‐Costello J, Muntane G, Garay A, Alcade‐Martinez V, Fernandez SL, Rivera‐Lopez R, Puga‐Martinez M, Fernandez‐Alvarez M, Serrano‐Martinez J, Crespo‐Leiro M, Grille‐Cancela Z, Marzoa‐Rivas R, Blanco‐Canosa P, Paniagua‐Martin M, Barge‐Caballero E, Cerdena IL, Baldomero IFH, Padron AL, Rosillo SO, Gonzalez‐Gallarza RD, Montanes OS, Manjavacas AI, Conde AC, Araujo A, Soria T, Garcia‐Pavia P, Gomez‐Bueno M, Cobo‐Marcos M, Alonso‐Pulpon L, Cubero JS, Sayago I, Gonzalez‐Segovia A, Briceno A, Subias PE, Hernandez MV, Cano MR, Sanchez MG, Jimenez JD, Garrido‐Lestache EB, Pinilla JG, Villa BG, Sahuquillo A, Marques RB, Calvo FT, Perez‐Martinez M, Gracia‐Rodenas M, Garrido‐Bravo IP, Pastor‐Perez F, Pascual‐Figal D, Molina BD, Orus J, Gonzalo FE, Bertomeu V, Valero R, Martinez‐Abellan R, Quiles J, Rodrigez‐Ortega J, Mateo I, ElAmrani A, Fernandez‐Vivancos C, Valero DB, Almenar‐Bonet L, Sanchez‐Lazaro I, Marques‐Sule E, Facila‐Rubio L, Perez‐Silvestre J, Garcia‐Gonzalez P, Ridocci‐Soriano F, Garcia‐Escriva D, Pellicer‐Cabo A, Fuente Galan L, Diaz JL, Platero AR, Arias J, Blasco‐Peiro T, Julve MS, Sanchez‐Insa E, Aured‐Guallar C, Portoles‐Ocampo A, Melin M, Hägglund E, Stenberg A, Lindahl I, Asserlund B, Olsson L, Dahlström U, Afzelius M, Karlström P, Tengvall L, Wiklund P, Olsson B, Kalayci S, Temizhan A, Cavusoglu Y, Gencer E, Yilmaz M, Gunes H. In‐hospital and 1‐year mortality associated with diabetes in patients with acute heart failure: results from the
ESC‐HFA
Heart Failure Long‐Term Registry. Eur J Heart Fail 2016; 19:54-65. [DOI: 10.1002/ejhf.679] [Citation(s) in RCA: 105] [Impact Index Per Article: 13.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/10/2016] [Revised: 08/24/2016] [Accepted: 09/20/2016] [Indexed: 12/28/2022] Open
Affiliation(s)
- Giovanni Targher
- Division of Endocrinology, Diabetes and Metabolism, Department of Medicine University and Azienda Ospedaliera Universitaria Integrata of Verona Verona Italy
| | - Marco Dauriz
- Division of Endocrinology, Diabetes and Metabolism, Department of Medicine University and Azienda Ospedaliera Universitaria Integrata of Verona Verona Italy
| | - Cécile Laroche
- EURObservational Research Programme European Society of Cardiology Sophia‐Antipolis France
| | | | | | | | | | - Roberto Ferrari
- Department of Cardiology and LTTA Centre, University Hospital of Ferrara and Maria Cecilia Hospital, GVM Care & Research E.S: Health Science Foundation Cotignola Italy
| | - Stephan Anker
- Innovative Clinical Trials, Department of Cardiology & Pneumology University Medical Center Göttingen (UMG) Göttingen Germany
| | - Andrew Coats
- Monash University Australia and University of Warwick Coventry UK
| | | | - Maria G. Crespo‐Leiro
- Unidad de Insuficiencia Cardiaca Avanzada y Trasplante Cardiaco, Complexo Hospitalario Universitario A Coruna CHUAC La Coruna Spain
| | - Alexandre Mebazaa
- Inserm 942, Hôpital Lariboisière Université Paris Diderot Paris France
| | - Massimo F. Piepoli
- Department of Cardiology Polichirurgico Hospital G. da Saliceto Piacenza Italy
| | - Aldo Pietro Maggioni
- EURObservational Research Programme European Society of Cardiology Sophia‐Antipolis France
- ANMCO Research Center Florence Italy
| | - Luigi Tavazzi
- Maria Cecilia Hospital, GVM Care & Research E.S. Health Science Foundation Cotignola Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
42
|
|
43
|
Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs J, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M. Corrigendum to: 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2015. [PMID: 26224077 DOI: 10.1093/eurheartj/ehu479] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
44
|
Tornvall P, Gerbaud E, Behaghel A, Chopard R, Collste O, Laraudogoitia E, Leurent G, Meneveau N, Montaudon M, Perez-David E, Sörensson P, Agewall S. Myocarditis or "true" infarction by cardiac magnetic resonance in patients with a clinical diagnosis of myocardial infarction without obstructive coronary disease: A meta-analysis of individual patient data. Atherosclerosis 2015; 241:87-91. [PMID: 25967935 DOI: 10.1016/j.atherosclerosis.2015.04.816] [Citation(s) in RCA: 103] [Impact Index Per Article: 11.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/24/2014] [Revised: 04/29/2015] [Accepted: 04/30/2015] [Indexed: 12/17/2022]
Abstract
OBJECTIVE Myocardial Infarction with Non-Obstructed Coronary Arteries (MINOCA) is common, but the causes are to a large extent unknown. Thus, we aimed to study the prevalence of myocarditis and "true" myocardial infarction determined by cardiac magnetic resonance (CMR) imaging in MINOCA patients, and risk markers for these two conditions in this population. METHODS A search was made in the PubMed and Cochrane databases using the search terms "Myocardial infarction", "Coronary angiography", "Normal coronary arteries" and "MRI". All relevant abstracts were read and seven of the studies fulfilled the inclusion criteria; studies describing case series of patients fulfilling the diagnosis of acute myocardial infarction with normal or non-obstructive coronary arteries on coronary angiography that were investigated with CMR imaging. Data from five of these studies are presented. RESULTS A total of 556 patients from 5 different sites were included. Fifty-one percent were men with a mean age of 52 ± 16 years. Thirty-three per cent of the patients had myocarditis (n = 183), whereas 21% of the patients had infarction on CMR (n = 115). Young age and a high CRP were associated with myocarditis whereas male sex, treated hyperlipidemia, high troponin ratio and low CRP were associated with "true" myocardial infarction. CONCLUSION AND RELEVANCE The results of this meta-analysis of individual data showed that myocarditis and "true" myocardial infarction are common in MINOCA when determined by CMR imaging. This information emphasizes the importance of performing CMR imaging in MINOCA patients and can be used clinically to guide diagnostics and treatment of MINOCA patients.
Collapse
Affiliation(s)
- P Tornvall
- Cardiology Unit, Department of Clinical Science and Education Södersjukhuset, Karolinska Institutet, Sweden.
| | - E Gerbaud
- Soins Intensifs Cardiologiques, Plateau de Cardiologie Interventionnelle, CHU de Bordeaux, Hôpital du Haut Lévêque, 5 Avenue de Magellan, F33604 Pessac, France
| | - A Behaghel
- CHU de Rennes, Service de Cardiologie et Maladies Vasculaires, INSERM, U1099, Université de Rennes 1, LTSI, Rennes, France
| | - R Chopard
- Department of Cardiology, EA 3920, University Hospital Jean Minjoz, 25000 Besancon, France
| | - O Collste
- Cardiology Unit, Department of Clinical Science and Education Södersjukhuset, Karolinska Institutet, Sweden
| | | | - G Leurent
- CHU de Rennes, Service de Cardiologie et Maladies Vasculaires, INSERM, U1099, Université de Rennes 1, LTSI, Rennes, France
| | - N Meneveau
- Department of Cardiology, EA 3920, University Hospital Jean Minjoz, 25000 Besancon, France
| | - M Montaudon
- Unité d'Imagerie Thoracique et Cardiovasculaire, CHU de Bordeaux, Hôpital du Haut Lévêque, 5 Avenue de Magellan, F33604 Pessac, France
| | | | - P Sörensson
- Cardiology Unit, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Sweden
| | - S Agewall
- Department of Cardiology, Oslo University Hospital Ullevål, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| |
Collapse
|
45
|
Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs JSR, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M. Corrigendum to:2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism:. Eur Heart J 2015; 36:2666. [DOI: 10.1093/eurheartj/ehv131] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
46
|
Quinart S, Mourot L, Nègre V, Simon-Rigaud ML, Nicolet-Guénat M, Bertrand AM, Meneveau N, Mougin F. Ventilatory thresholds determined from HRV: comparison of 2 methods in obese adolescents. Int J Sports Med 2013; 35:203-8. [PMID: 23945974 DOI: 10.1055/s-0033-1345172] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
The development of personalised training programmes is crucial in the management of obesity. We evaluated the ability of 2 heart rate variability analyses to determine ventilatory thresholds (VT) in obese adolescents. 20 adolescents (mean age 14.3±1.6 years and body mass index z-score 4.2±0.1) performed an incremental test to exhaustion before and after a 9-month multidisciplinary management programme. The first (VT1) and second (VT2) ventilatory thresholds were identified by the reference method (gas exchanges). We recorded RR intervals to estimate VT1 and VT2 from heart rate variability using time-domain analysis and time-varying spectral-domain analysis. The coefficient correlations between thresholds were higher with spectral-domain analysis compared to time-domain analysis: Heart rate at VT1: r=0.91 vs. =0.66 and VT2: r=0.91 vs. =0.66; power at VT1: r=0.91 vs. =0.74 and VT2: r=0.93 vs. =0.78; spectral-domain vs. time-domain analysis respectively). No systematic bias in heart rate at VT1 and VT2 with standard deviations <6 bpm were found, confirming that spectral-domain analysis could replace the reference method for the detection of ventilatory thresholds. Furthermore, this technique is sensitive to rehabilitation and re-training, which underlines its utility in clinical practice. This inexpensive and non-invasive tool is promising for prescribing physical activity programs in obese adolescents.
Collapse
Affiliation(s)
- S Quinart
- EA3920, Prognostic Marker and Regulatory Factor of CardioVascular Disease, University of Franche-Comte, Besançon, France
| | - L Mourot
- EA 4660 Culture Sport Health Society and Exercise Performance, Health, Innovation Platform, University of Franche-Comté, Besançon, France
| | - V Nègre
- Pediatric Obesity Prevention and Rehabilitation Department, CHRU, Besançon, France
| | | | - M Nicolet-Guénat
- SSR La Beline, Childhood Obesity Rehabilitation Centre, Salins-les-Bains, France
| | - A-M Bertrand
- Pediatric Obesity Prevention and Rehabilitation Department, CHRU, Besançon, France
| | - N Meneveau
- EA3920, Prognostic Marker and Regulatory Factor of CardioVascular Disease, University of Franche-Comte, Besançon, France
| | - F Mougin
- EA3920, Prognostic Marker and Regulatory Factor of CardioVascular Disease, University of Franche-Comte, Besançon, France
| |
Collapse
|
47
|
Koc M, Elikowski W, Meneveau N, Lankeit M, Kostrubiec M, Grifoni S, Hugues T, Pruszczyk P. Right heart thrombi european registry - preliminary results. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht308.759] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
48
|
Meneveau N, Puymirat E, Allam S, Huguet RG, Schiele F, Ferrieres J, Simon T, Danchin N. Renal insufficiency impacts on early and late mortality after acute coronary syndrome after adjustment for comorbidities and management. Insights from the FAST MI 2005 registry. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht308.p922] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
49
|
Meneveau N, Huang J, Belmadani K, Plastaras P, Chopard R, Janin S, Schiele F. Does optical coherence tomography-guided angioplasty yield additional clinical information and modify physician strategy? Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht309.p3923] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
50
|
Chopard R, Meneveau N, Gilard M, Laskar M, Eltchaninoff H, Iung B, Teiger E, Leguerrier A, Leprince P, Schiele F. Impact of chronic obstructive pulmonary disease on one year mortality after transcatheter aortic valve implantation. A substudy from the FRANCE 2 nationwide registry. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht310.p5395] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|